Listed

ICU Medical Inc: Form 10-Q for the period ended Sep 30, 2010

Filed with the SEC on Oct 22, 2010 and accepted by EDGAR at Oct 22, 2010, 10:17 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2010-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2010-07-01 to 2010-09-30$75.7mus-gaap:Revenues
Revenue9 months2010-01-01 to 2010-09-30$209.0mus-gaap:Revenues
Cost of revenue3 months2010-07-01 to 2010-09-30$41.7mus-gaap:CostOfGoodsSold
Cost of revenue9 months2010-01-01 to 2010-09-30$115.9mus-gaap:CostOfGoodsSold
Gross profit3 months2010-07-01 to 2010-09-30$34.0mus-gaap:GrossProfit
Gross profit9 months2010-01-01 to 2010-09-30$93.1mus-gaap:GrossProfit
Research and development3 months2010-07-01 to 2010-09-30$1.1mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2010-01-01 to 2010-09-30$2.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2010-07-01 to 2010-09-30$18.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2010-01-01 to 2010-09-30$57.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2010-07-01 to 2010-09-30$14.6mus-gaap:OperatingIncomeLoss
Operating income9 months2010-01-01 to 2010-09-30$32.8mus-gaap:OperatingIncomeLoss
Income tax3 months2010-07-01 to 2010-09-30$5.4mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2010-01-01 to 2010-09-30$11.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2010-07-01 to 2010-09-30$9.0mus-gaap:ProfitLoss
Net income9 months2010-01-01 to 2010-09-30$20.9mus-gaap:ProfitLoss
Diluted EPS3 months2010-07-01 to 2010-09-30$0.65us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2010-01-01 to 2010-09-30$1.51us-gaap:EarningsPerShareDiluted
Basic EPS3 months2010-07-01 to 2010-09-30$0.67us-gaap:EarningsPerShareBasic
Basic EPS9 months2010-01-01 to 2010-09-30$1.54us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2010-07-01 to 2010-09-3013,752,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2010-01-01 to 2010-09-3013,838,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2010-01-01 to 2010-09-30$18.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2010-01-01 to 2010-09-30$17.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2010-01-01 to 2010-09-30$28.6mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2010-09-30$65.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2010-09-30$195.4mus-gaap:AssetsCurrent
Total assetsAt period end2010-09-30$300.4mus-gaap:Assets
Current liabilitiesAt period end2010-09-30$26.6mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2010-09-30$262.3mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Shares outstandingAt period end2010-10-1013,591,805 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001104659-10-053238. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.